UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Discovery of a Potent, Orally Available, and Isoform-Selective Retinoic Acid β2 Receptor Agonist

Journal of medicinal chemistry, 2005-12, Vol.48 (24), p.7517-7519

2005

Link zum Volltext

Verfügbarkeit prüfen

Optimization of isochromanone based urotensin II receptor agonists

Bioorganic & medicinal chemistry, 2010-07, Vol.18 (13), p.4844-4854

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel subtype selective RAR agonists

Biochemical pharmacology, 2005-12, Vol.71 (1), p.156-162

2005

Link zum Volltext

Verfügbarkeit prüfen

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Schizophrenia research, 2012-11, Vol.141 (2), p.144-152

2012

Link zum Volltext

Verfügbarkeit prüfen

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

Naunyn-Schmiedeberg's archives of pharmacology, 1993-04, Vol.347 (4), p.353-362

1993

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Structure−Activity Analysis of Isoform-Selective Retinoic Acid Receptor β Ligands

Journal of medicinal chemistry, 2009-03, Vol.52 (6), p.1540-1545

2009

Link zum Volltext

Verfügbarkeit prüfen

Design, parallel synthesis and SAR of novel urotensin II receptor agonists

European journal of medicinal chemistry, 2007-02, Vol.42 (2), p.276-285

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the Binding Site of the Histamine H3 Receptor. 1. Various Approaches to the Synthesis of 2-(1H-Imidazol-4-yl)cyclopropylamine and Histaminergic Activity of (1R,2R)- and (1S,2S)-2-(1H-Imidazol-4-yl)- cyclopropylamine

Journal of medicinal chemistry, 1999-04, Vol.42 (7), p.1115-1122

1999

Link zum Volltext

Verfügbarkeit prüfen

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

Journal of medicinal chemistry, 2006-04, Vol.49 (7), p.2232-2240

2006

Link zum Volltext

Verfügbarkeit prüfen

3-Heteroaryl-Substituted Quinuclidin-3-ol and Quinuclidin-2-ene Derivatives as Muscarinic Antagonists. Synthesis and Structure-Activity Relationships

Journal of medicinal chemistry, 1995-02, Vol.38 (3), p.473-487

1995

Link zum Volltext

Verfügbarkeit prüfen

Isochromanone-based urotensin-II receptor agonists

Bioorganic & medicinal chemistry, 2005-04, Vol.13 (8), p.3057-3068

2005

Link zum Volltext

Verfügbarkeit prüfen

Novel and potent small-molecule urotensin II receptor agonists

Bioorganic & medicinal chemistry, 2009-07, Vol.17 (13), p.4657-4665

2009

Link zum Volltext

Verfügbarkeit prüfen

(R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41) : two novel 5-HT1A receptor agonists

European journal of pharmacology, 1993-01, Vol.231 (1), p.69-76

1993

Link zum Volltext

Verfügbarkeit prüfen

Discovery of the First Nonpeptide Agonist of the GPR14/Urotensin-II Receptor: 3-(4-Chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)

Journal of medicinal chemistry, 2002-11, Vol.45 (23), p.4950-4953

2002

Link zum Volltext

Verfügbarkeit prüfen

Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches

Journal of medicinal chemistry, 1993-04, Vol.36 (8), p.967-976

1993

Link zum Volltext

Verfügbarkeit prüfen

Atropisomeric Derivatives of 2‘,6‘-Disubstituted (R)-11-Phenylaporphine: Selective Serotonin 5-HT7 Receptor Antagonists

Journal of medicinal chemistry, 2001-04, Vol.44 (9), p.1337-1340

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of polymorphic variants of the human 5-HT1A receptor

Biochemical pharmacology, 2004-02, Vol.67 (3), p.479-490

2004

Link zum Volltext

Verfügbarkeit prüfen

Analysis of molecular determinants of affinity and relative efficacy of a series of R‐ and S‐2‐(dipropylamino)tetralins at the 5‐HT1A serotonin receptor

British journal of pharmacology, 2003-03, Vol.138 (6), p.1129-1139

2003

Link zum Volltext

Verfügbarkeit prüfen

Derivatives of (R)-1,11-Methyleneaporphine: Synthesis, Structure, and Interactions with G-Protein Coupled Receptors

Journal of medicinal chemistry, 2000-04, Vol.43 (7), p.1339-1349

2000

Link zum Volltext

Verfügbarkeit prüfen

Derivatives of 17-phenyl-18,19,20-trinorprostaglandin F2α isopropyl ester : potential antiglaucoma agents

Journal of medicinal chemistry, 1995-01, Vol.38 (2), p.289-304

1995

Link zum Volltext

Verfügbarkeit prüfen

Antimuscarinic 3-(2-Furanyl)quinuclidin-2-ene Derivatives: Synthesis and Structure−Activity Relationships

Journal of medicinal chemistry, 1997-11, Vol.40 (23), p.3804-3819

1997

Link zum Volltext

Verfügbarkeit prüfen

Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase

Molecular pharmacology, 1991-06, Vol.39 (6), p.780-787

1991

Link zum Volltext

Verfügbarkeit prüfen

trans-2-Aryl-N,N-dipropylcyclopropylamines: Synthesis and Interactions with 5-HT1A Receptors

Journal of medicinal chemistry, 1996-03, Vol.39 (7), p.1485-1493

1996

Link zum Volltext

Verfügbarkeit prüfen

Interactions of ligands with active and inactive conformations of the dopamine D2 receptor

European journal of pharmacology, 1998-04, Vol.346 (2-3), p.299-307

1998

Link zum Volltext

Verfügbarkeit prüfen

Differential serotoninergic and dopaminergic activities of the (R) - and the (S) -enantiomers of 2-(di-n-propylamino) tetralin

European journal of pharmacology, 1996-05, Vol.303 (3), p.151-162

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(43)
Pharmacology. Drug Treatments
(41)
Neuropharmacology
(36)
Animals
(35)
Life Sciences & Biomedicine
(33)
Neurotransmitters. Neurotransmission. Receptors
(33)
Science & Technology
(33)
Pharmacology & Pharmacy
(30)
Rats
(20)
Structure-Activity Relationship
(20)
Chemistry, Medicinal
(19)
Humans
(18)
Stereoisomerism
(16)
Male
(15)
Serotoninergic System
(12)
Mice
(9)
Models, Molecular
(9)
Binding, Competitive
(8)
In Vitro Techniques
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of a Potent, Orally Available, and Isoform-Selective Retinoic Acid β2 Receptor Agonist

Optimization of isochromanone based urotensin II receptor agonists

Identification of novel subtype selective RAR agonists

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

Design, Synthesis, and Structure−Activity Analysis of Isoform-Selective Retinoic Acid Receptor β Ligands

Design, parallel synthesis and SAR of novel urotensin II receptor agonists

Characterization of the Binding Site of the Histamine H3 Receptor. 1. Various Approaches to the Synthesis of 2-(1H-Imidazol-4-yl)cyclopropylamine and Histaminergic Activity of (1R,2R)- and (1S,2S)-2-(1H-Imidazol-4-yl)- cyclopropylamine

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

3-Heteroaryl-Substituted Quinuclidin-3-ol and Quinuclidin-2-ene Derivatives as Muscarinic Antagonists. Synthesis and Structure-Activity Relationships

Isochromanone-based urotensin-II receptor agonists

Novel and potent small-molecule urotensin II receptor agonists

(R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41) : two novel 5-HT1A receptor agonists

Discovery of the First Nonpeptide Agonist of the GPR14/Urotensin-II Receptor: 3-(4-Chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)

Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches

Atropisomeric Derivatives of 2‘,6‘-Disubstituted (R)-11-Phenylaporphine: Selective Serotonin 5-HT7 Receptor Antagonists

Pharmacology of polymorphic variants of the human 5-HT1A receptor

Analysis of molecular determinants of affinity and relative efficacy of a series of R‐ and S‐2‐(dipropylamino)tetralins at the 5‐HT1A serotonin receptor

Derivatives of (R)-1,11-Methyleneaporphine: Synthesis, Structure, and Interactions with G-Protein Coupled Receptors

Derivatives of 17-phenyl-18,19,20-trinorprostaglandin F2α isopropyl ester : potential antiglaucoma agents

Antimuscarinic 3-(2-Furanyl)quinuclidin-2-ene Derivatives: Synthesis and Structure−Activity Relationships

Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase

trans-2-Aryl-N,N-dipropylcyclopropylamines: Synthesis and Interactions with 5-HT1A Receptors

Interactions of ligands with active and inactive conformations of the dopamine D2 receptor

Differential serotoninergic and dopaminergic activities of the (R) - and the (S) -enantiomers of 2-(di-n-propylamino) tetralin

Aktive Filter

Suchergebnisse filtern